3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 3, 2008, Pages 337-341

  Carpagnano, Giovanna Elisiana ^a,g   Foschino Barbaro, Maria Pia ^a   Spanevello, Antonio ^b   Resta, Onofrio ^c   Carpagnano, Francesco ^d   Mulé, Giuseppina ^e   Pinto, Rosamaria ^f   Tommasi, Stefania ^f   Paradiso, Angelo ^f  

^a UNIVERSITY OF FOGGIA   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d SAN PAOLO HOSPITAL   (Italy)

^e INSTITUTE OF SCIENCES OF FOOD PRODUCTION   (Italy)

^f NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^g NONE   (Italy)

Author keywords

DNA; Exhaled breath condensate; Lung tissue; Non small cell lung cancer

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 3P; CONTROLLED STUDY; EXHALATION; FEMALE; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; PRIORITY JOURNAL; SMOKING;

AGED; BIOLOGICAL MARKERS; BLOOD CELLS; BREATH TESTS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; EXHALATION; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; SMOKING;

EID: 38849104761     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200707-1136OC     Document Type: Article

References (20)

1. Panani AD, Roussos C. Cytogenetic and molecular aspects of lung cancer. Cancer Lett 2006;239:1-9.
2. Capkova L, Kalinova M, Krskova L, Kodetova D, Petrik F, Trefny M, Musil J, Kodet R. Loss of heterozygosity and human telomerase reverse transcriptase (hTERT) expression in bronchial mucosa of heavy smokers. Cancer 2007;109:2299-2307.
3. Loeb AL. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1991;54:5059-5063.
4. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet SS, Srivastava S, Minna JD, Gazdar AF. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997;89:1366-1373.
5. Sozzi G, Musso K, Ratcliffe C, Goldstraw P, Pierotti MA, Pastorino U. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis. Clin Cancer Res 1999;5:2689-2692.
6. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, Herman JG, Wu L, Decker PA, Jen J, et al. Moleculare detection of tumour cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999;91:332-339.
7. Zhou J, Nong L, Wloch M, Cantor A, Mulshine JL, Tockman MS. Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. Lung Cancer 2001;34:341-350.
8. Beau-Faller M, Gaub MP, Schneider A, Ducrocq X, Massard G, Gasser B, Chenard MP, Kessler R, Anker P, Stroun M, et al. Whole blood DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients. Int J Cancer 2003;105:361-370.
9. INK4A gene in resected nonsmall cell lung tumors and exfoliated cells within sputum. Int J Cancer 2002;98:724-731.
10. Carpagnano GE, Foschino-Barbaro MP, Mulé G, Resta O, Tommasi S, Mangia A, Carpagnano F, Stea G, Susca A, Di Gioia G, et al. 3p Microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. Am J Respir Crit Care Med 2005;172:738-744.
11. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002. Chapter 19, Lung; p. 167-178.
12. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005;171:1077-1082.
13. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 2003;167:1109-1112.
14. Carpagnano GE, Barnes PJ, Francis J, Wilson N, Bush A, Kharitonov SA. Breath condensate pH in children with CF and asthma: a new non-invasive marker of airway inflammation? Chest 2004;125:2005-2010.
15. Sozzi G, Conte D, Mariani S, Lo Vullo S, Roz L, Lombardo C, Pierotti MA, Tavecchio L. Analysis of circulating tumor DNA in whole blood at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001;61:4675-4678.
16. Sanchez-Cespedes M, Rosell R, Pifarre A, Lopez-Cabrerizo MP, Barnadas A, Sanchez JJ, Lorenzo JC, Abad A, Monzo M, Navas-Palacios JJ. Microsatellite alterations at 5q21, 11p13 and 11p15.5 do not predict survival in non small cell lung cancer. Clin Cancer Res 1997;3:1229-1235.
17. Endo C, Sagawa M, Sato M, Chen Y, Sakurada A, Aikawa H, Takahashi S, Usuda K, Saito Y, Fujimura S. Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung. Br J Cancer 1998;78:612-615.
18. Yohena T, Yoshino I, Takenaka T, Ohba T, Kouso H, Osoegawa A, Hamatake M, Oda S, Kuniyoshi Y, Maehara Y. Relationship between the loss of heterozygosity and tobacco smoking in pulmonary adenocarcinoma. Oncol Res 2007;16:333-339.
19. Tai AL, Mak W, Ng PK, Chua DT, Ng MY, Fu L, Chu KK, Fang Y, Qiang Song Y, Chen M, et al. High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers. Cancer Res 2006;66:4133-4138.
20. Holschneider CH, Baldwin RL, Tumber K, Aoyama C, Karlan BY. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer. Clin Cancer Res 2005;11:5756-5763.